US 8680066
Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject
granted A61KA61K31/166A61K31/4155
Quick answer
US patent 8680066 (Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject) held by The United States of America as represented by the Development of Veterans Affairs expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Development of Veterans Affairs
- Grant date
- Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/166, A61K31/4155, A61K31/4184, A61K31/426